Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia

Tekijä Butler, Peter C.
Julkaistu 2009

Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes

Tekijä Butler, Peter C.
Julkaistu 2011

Glucagon-Like Peptide 1 Drugs as Second-Line Therapy for Type 2 Diabetes

Tekijä Butler, Peter C.
Julkaisussa JAMA Intern Med (2016)

Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?

Tekijä Costes, Safia, Butler, Peter C.
Julkaistu 2014

GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You

Tekijä Butler, Peter C., Dry, Sarah, Elashoff, Robert
Julkaistu 2010

Evaluation of immunohistochemical staining for glucagon in human pancreatic tissue

Tekijä Gurlo, Tatyana, Butler, Peter C., Butler, Alexandra E.
Julkaisussa J Histotechnol (2016)

Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein

Tekijä Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Julkaistu 2008

Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats

Tekijä Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Julkaistu 2008

Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

Tekijä Satin, Leslie S., Butler, Peter C., Ha, Joon, Sherman, Arthur S.
Julkaisussa Mol Aspects Med (2015)

Many Commercially Available Antibodies for Detection of CHOP Expression as a Marker of Endoplasmic Reticulum Stress Fail Specificity Evaluation

Tekijä Haataja, Leena, Gurlo, Tatyana, Huang, Chang-jiang, Butler, Peter C.
Julkaistu 2008

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

Tekijä Haataja, Leena, Gurlo, Tatyana, Huang, Chang J., Butler, Peter C.
Julkaistu 2008

Response to Comment on: Saisho et al. β-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111–117

Tekijä Saisho, Yoshifumi, Butler, Alexandra E., Manesso, Erica, Butler, Peter C.
Julkaistu 2013

Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats

Tekijä Matveyenko, Aleksey V., Georgia, Senta, Bhushan, Anil, Butler, Peter C.
Julkaistu 2010

UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: Evidence of interplay between the ubiquitin/proteasome system and autophagy

Tekijä Costes, Safia, Gurlo, Tatyana, Rivera, Jacqueline F, Butler, Peter C
Julkaistu 2014

Type 2 Diabetes as a Protein Misfolding Disease

Tekijä Mukherjee, Abhisek, Morales-Scheihing, Diego, Butler, Peter C., Soto, Claudio
Julkaisussa Trends Mol Med (2015)

Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes

Tekijä Moin, Abu Saleh Md, Butler, Peter C., Butler, Alexandra E.
Julkaisussa J Clin Endocrinol Metab (2016)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

Tekijä Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Julkaistu 2013

Down Syndrome-Associated Diabetes Is Not Due To a Congenital Deficiency in β Cells

Tekijä Butler, Alexandra E., Sacks, Wendy, Rizza, Robert A., Butler, Peter C.
Julkaisussa J Endocr Soc (2017)

Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways

Tekijä Daval, Marie, Gurlo, Tatyana, Costes, Safia, Huang, Chang-jiang, Butler, Peter C.
Julkaistu 2011

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

Tekijä Costes, Safia, Langen, Ralf, Gurlo, Tatyana, Matveyenko, Aleksey V., Butler, Peter C.
Julkaistu 2013